36.11 USD
▲-0.10+2.01%
盘后 35.50 +0.28%
2026-08-03
市值
$3.43B
市盈率
—
EPS
-1.58
股息率
—
52 周区间
22.09 – 40.58
成交量
1.25M
Beta
-0.09
目标价
53.54
52W 低 22.0952W 高 40.58
价格走势
公司简介
IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase, C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoadjuvant, and adjuvant settings. The company also offers IDE849, a DLL3 antibody drug conjugate inhib...